These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29864500)

  • 1. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps.
    Mitgang EA; Hartley DM; Malchione MD; Koch M; Goodman JL
    Int J Antimicrob Agents; 2018 Sep; 52(3):372-384. PubMed ID: 29864500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
    Malchione MD; Torres LM; Hartley DM; Koch M; Goodman JL
    Int J Antimicrob Agents; 2019 Oct; 54(4):381-399. PubMed ID: 31369812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.
    Venne DM; Hartley DM; Malchione MD; Koch M; Britto AY; Goodman JL
    Antimicrob Resist Infect Control; 2023 Apr; 12(1):29. PubMed ID: 37013626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
    Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
    Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China.
    Gong X; Zhang J; Su S; Fu Y; Bao M; Wang Y; Zhang X
    BMC Infect Dis; 2018 Aug; 18(1):417. PubMed ID: 30134844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Enterobacteriaceae in Pediatric Bloodstream Infections in Rural Southern India.
    Sekar R; Mythreyee M; Srivani S; Sivakumaran D; Lallitha S; Saranya S
    Indian Pediatr; 2017 Dec; 54(12):1021-1024. PubMed ID: 28849764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
    Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.
    Mortensen JE; DeBurger B; Powell EA; DiFranco-Fisher J; Koeth L; Weissman SJ
    J Glob Antimicrob Resist; 2016 Dec; 7():141-144. PubMed ID: 27835839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Mechanisms of Carbapenem Resistance in
    Nasiri MJ; Mirsaeidi M; Mousavi SMJ; Arshadi M; Fardsanei F; Deihim B; Davoudabadi S; Zamani S; Hajikhani B; Goudarzi H; Goudarzi M; Seghatoleslami ZS; Dabiri H; Tabarsi P
    Microb Drug Resist; 2020 Dec; 26(12):1491-1502. PubMed ID: 32348701
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of varying federal definitions on prevalence and characteristics associated with carbapenem-resistant Enterobacteriaceae in veterans with spinal cord injury.
    Fitzpatrick MA; Suda KJ; Jones MM; Burns SP; Poggensee L; Ramanathan S; Evans M; Evans CT
    Am J Infect Control; 2019 Feb; 47(2):175-179. PubMed ID: 30301655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of carbapenem-resistant Enterobacteriaceae infections.
    Durante-Mangoni E; Andini R; Zampino R
    Clin Microbiol Infect; 2019 Aug; 25(8):943-950. PubMed ID: 31004767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rapid spread of carbapenem-resistant Enterobacteriaceae.
    Potter RF; D'Souza AW; Dantas G
    Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China.
    Yang Y; Chen J; Lin D; Xu X; Cheng J; Sun C
    Front Med; 2018 Apr; 12(2):182-188. PubMed ID: 28687975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.
    Zavascki AP; Klee BO; Bulitta JB
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):519-526. PubMed ID: 28375030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.